Anti-Snoring Devices Market - Focused Insights 2025-2030

The Anti-Snoring Devices Market was valued at USD 1.42 Billion in 2024, and is projected to reach USD 2.28 Billion by 2030, rising at a CAGR of 8.21%.

RECENT VENDORS ACTIVITIES

• Among the latest launches, smart anti-snoring devices have attracted much attention with AI-driven sleep tracking, biometric monitoring, and real-time adjustments. For Instance, in 2024, DeRUCCI Group developed and launched an anti-snoring pillow that enables patient monitoring, screening, and intervention to alleviate snoring and claims to reduce snoring by around 89%. Another major approval is eXciteOSA, approved by the US FDA- it is a daytime neuromuscular stimulation product that strengthens tongue muscles through electrical impulses, reducing airway collapse during sleep. Unlike typical MADs or CPAP devices, this device is utilized for only 20 minutes of the day and is thus revolutionary and practical.
• Custom 3D-printed MADs: some companies got approval to start manufacturing fully individualized, dentist-prescribed MADs with optimal fitness and efficiency. SomnoDent Avant is one of the most recognized products approved by the US FDA to treat snoring and mild to moderate obstructive sleep apnea (OSA). In the meantime, ZQuiet Pro Plus is a superior version of MAD, using living hinge technology, that has quickly been accepted for allowing natural mouth movement for better adaptation and ease of use.
• In 2023, Resmed acquired Somnoware which was one of the leading companies in digital sleep solutions. This acquisition will support the company to strengthen its anti-snoring devices portfolio.
• In 2024, Fisher & Paykel Healthcare launched of Nova Micro Nasal Pillows Mask to treat OSA in the US.

KEY TAKEAWAYS

• By Product: In 2024, the oral devices segment accounted for the highest market share of over 46%. Increased awareness of sleep apnea drives demand for oral devices like MADs and TRDs, which keep airways open by repositioning the jaw or tongue during sleep.
• By Age Group: The below 40-year-old age group shows incremental growth of USD 164.81 million, driven by the rising prevalence of sleep disorders and related health conditions.
• By Consumer: The men segment accounted for the largest market share, driven by habitual snoring which is a very common problem for men across the world.
• By End-Users: The sleep labs/dental clinics segment holds the largest global anti-snoring devices market share. Sleep laboratories are major medical facilities that perform a range of tests and a variety of diagnostics to identify sleep diseases, such as obstructive sleep apnea (OSA).
• By Geography: North America accounted for the largest share of over 32%, driven by advanced healthcare infrastructures, the high proficiency in the adoption of technologies, and a very large prevalence of chronic diseases.
• Growth Factor: The global anti-snoring devices market is set to grow due to the growing popularity of home-based devices and expanding applications of anti-snoring devices in health and wellness.

MARKET TRENDS & DRIVERS

Shift Towards Smart, Adaptive, And Contact Free Devices

Recently developed modern anti-snoring mouthpieces enable jaw positioning adjustment with the help of advanced technology and advanced materials while incorporating high-class sensors that can monitor snoring intensity. Recently developed smart anti-snoring devices come up with Bluetooth connection which allows individuals to monitor their sleep patterns using smartphone apps. Furthermore, the development of contact-free anti-snoring devices is expected to transform the industry in the future. For example, Smart Nora one of the anti-snoring device manufacturing companies developed a high-class contact-free anti-snoring device - SMART NORA which helps to reduce snoring as well as detect the actual cause of snoring.

Technological Advancements In CPAP Devices

The continued development in CPAP (Continuous Positive Airway Pressure) technology witnessed some advances, including smart connectivity, advanced adaptive pressure algorithms, compact design, mask technology advancements, and humidification and climate control. These advances support sleep apnea management. Smart connectivity is one of the major technology advancements in CPAP. Smart CPAP devices can connect to smartphones or tablets, enabling a person to monitor real-time therapy data. This technology provides vital insights into sleep patterns and treatment effectiveness as well as enables remote monitoring and ensures personalized and timely adjustment of sleep apnea.

Growing Popularity For Home-Based Devices

The demand for air anti-snoring devices, a rapidly developing branch of the anti-snoring device industry, is being actively driven by the rapid increase of home-based sleep solutions. Given the growing emphasis on sleep health, people are increasingly looking for non-invasive and inexpensive alternatives to medical treatment of snoring and other sleep disorders. The rapid growth of technology is helping in making home-based anti-snoring devices, more affordable, effective, and user-friendly than ever before. Perhaps one of the greatest catalysts driving the trend is the utilization of smart data-driven solutions that allow users to wholeheartedly process, analyze, and monitor their sleep patterns while remaining in the cozy comforts of their homes.

Expanding Applications Of Anti-Snoring Devices In Health And Wellness

The demand for anti-snoring devices is no longer limited to personal use. There is growing awareness about sleep-related health problems and these devices have found their places in clinical settings, rehabilitation centers, and corporate wellness programs. The direct correlation between the improvement in sleep quality with cognitive function and enhancement in productivity gets high attention from those organizations willing to enhance the well-being of all. Sleep clinics and medical institutions have included anti-snoring devices as a non-invasive treatment program for patients with mild to moderate obstructive sleep apnea (OSA) conditions and chronic snoring. Furthermore, these devices become highly popular and widely used in rehabilitation centers for post-surgical recovery or to treat conditions that have been exacerbated by lack of sleep, such as cardiovascular problems and metabolic disorders.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT

The global anti-snoring devices market by product is segmented into oral devices, PAP devices, Nasal devices, and others. In 2024, the oral devices segment accounted for the largest market share of over 46%. Oral anti-snoring appliances are considered a non-surgical treatment option for obstructive sleep apnea (OSA) and snoring. These devices are widely recognized as safe and effective treatments within the oral and dental field, gaining significant popularity in recent years. Technological advancements, such as mandibular advancement devices (MADs) and tongue-retaining devices (TRDs), have further contributed to their growing adoption. Oral devices offer comfort, effectiveness, and ease of use, making them a preferred choice for reducing snoring. They work by repositioning the jaw or tongue to prevent airway obstruction during sleep, thereby minimizing snoring.

INSIGHTS BY AGE GROUP

The global anti-snoring devices market by age group is categorized into between 40- & 59-years age group, 60 years & above age group, and below 40 years age group. The below-40 age group segment shows incremental growth of USD 164.81 million during the forecast period. A substantial proportion of individuals in this age group are witnessing an increasing prevalence of sleep disorders and related health conditions. While sleep apnea primarily affects middle-aged and elderly individuals, it is increasingly being diagnosed in those under 40 due to rising obesity rates and lifestyle factors. Obesity is a major health condition that significantly increases the risk of sleep apnea. The growing working population in this age group, combined with its impact on sleep health and the rising obesity rates, has led to a higher prevalence of OSA. These factors are driving the growth of this segment in the global anti-snoring devices market.

INSIGHTS BY CONSUMER

Based on the consumer, the men segment accounts for the largest global anti-snoring devices market share. While both men and women are affected by snoring and sleep apnea, men tend to snore more frequently, with habitual snoring observed in approximately 40% of men compared to 25% of women. The higher prevalence of sleep apnea in men is primarily due to anatomical factors, such as larger airways and a heavier distribution of fat around the neck, which increases the likelihood of airway obstruction during sleep. Additionally, the significant burden of obstructive sleep apnea among men is influenced by factors such as higher obesity rates, the prevalence of chronic diseases, a large working population, and unhealthy lifestyle habits. These factors have led to a growing demand for anti-snoring devices among men.

INSIGHTS BY END-USERS

Based on the end-users, the sleep labs/dental clinics segment dominates the global anti-snoring devices market share. Sleep laboratories are major medical facilities that conduct a range of tests and diagnostics to identify sleep disorders, such as obstructive sleep apnea (OSA). These facilities commonly utilize various patient monitoring solutions and anti-snoring devices to assess the severity of snoring conditions. Based on diagnostic findings, medical professionals at sleep laboratories often prescribe anti-snoring devices or treatments, including Continuous Positive Airway Pressure (CPAP) therapy, Mandibular Advancement Devices (MADs), or positional therapy aids. Globally, the increasing number of sleep laboratories is driving the demand for anti-snoring devices. Additionally, dental clinics play a crucial role in offering therapies and oral appliances, such as mandibular advancement devices, for the treatment of OSA. Their contributions are significantly fueling market growth.

GEOGRAPHICAL ANALYSIS

In the global anti-snoring devices market, North America accounted for the largest share of over 32%. In North America, a significant proportion of adults and older individuals experience sleep apnea and are seeking better solutions. Increasing awareness, technological advancements, the rising prevalence of sleep apnea, and the availability of wearable and user-friendly anti-snoring devices are accelerating market growth. Within North America, the U.S. holds the largest share of the anti-snoring devices market. Sleep apnea is a major health concern among the U.S. population, particularly among older adults. According to the American Academy of Sleep Medicine, more than 30 million people in the U.S. were diagnosed with sleep apnea in 2024. If left untreated, sleep apnea increases the risk of several health issues, including heart disease, depression, and diabetes.

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
• APAC
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • South Africa

COMPETITIVE LANDSCAPE

The global anti-snoring devices market report contains exclusive data on 29 vendors. Apnea Sciences, Fisher & Paykel Healthcare, Koninklijke Philips, ResMed, and Tomed are some of the leading companies that accounted for the highest market share in the global anti-snoring devices market. These vendors offer high-class, comfortable, and reliable solutions that meet consumers' requirements and international regulations. Leading vendors are increasing the efficiency of their products, and strengthening their market position. These companies have a strong brand image and wide geographical reach across the global market. Also, the adoption of various strategies, such as product launches, new product development with advanced materials and technologies, and acquisitions intensified the competition in the market. The adoption of such strategies by the vendors and their focus on expanding their capabilities have enabled them to gain a higher revenue share in the market.

Key Vendors

• Apnea Sciences
• Fisher & Paykel Healthcare Corporation Limited
• Koninklijke Philips
• ResMed
• Tomed

Other Prominent Vendors

• DynaFlex
• DeRUCCI International Holding
• Drive DeVilbiss Healthcare
• Glidewell
• Humetron Corp
• Illusion Aligners
• MEDiTAS Limited
• Nidra Care
• Nitetronic
• Nyxoah
• Open Airway Dental Solutions Ltd. (OADS)
• ProSomnus Sleep Technologies
• REM-Fit
• REMSleep Holdings, Inc.
• Rhinomed Limited
• Signifier Medical Technologies
• Sleep Number Corporation
• Smart Nora
• SomnoMed Limited
• Somnowell
• Vivos Therapeutics
• VVFLY Electronics Co., Ltd.
• White Dental Healthcare
• ZQuiet

SEGMENTATION & FORECAST

• By Product
  • Oral Devices
  • PAP Devices
  • Nsala Devices
  • Others
• By Age Group
  • Between 40- & 59-Years Age Group
  • 60 Years & Above Age Group
  • Below 40 Years Age Group
• By Consumer
  • Men
  • Women
• By End-Users
  • Sleep Labs/Dental Clinics
  • Home Healthcare
  • Hospitals

KEY QUESTIONS ANSWERED

1. How big is the global anti-snoring devices market?
2. Which region dominates the global anti-snoring devices market?
3. What are the factors driving the global anti-snoring devices market growth?
4. Who are the major players in the global anti-snoring devices market?